Affiliates of private equity firm Altus Capital Partners agreed to pay $11.03 per share for MGC Diagnostics, which makes equipment that monitor's a person's heart rate and breathing. MGC Diagnostics ...

St. Paul's MGC Diagnostics will buy Belgium-based Medisoft, which also makes systems for detecting heart and lung disease, in a deal it called "mission critical." A Minnesota maker of systems for ...

St. Paul-based MGC Diagnostics, which makes equipment for diagnosing asthma and lung disease, announced the completion of its acquisition by the private equity firm Altus Capital Partners Inc at $50.3 ...

MGC Diagnostics Corporation, formerly known as Angeion Corporation, has sold assets of its New Leaf business to Chanhassen-based Life Time Fitness, Inc. Under the terms of the deal, Life Time paid ...

MGC, which is backed by Altus Capital Partners, has acquired Lemon Medical, a German medical tech company. No financial terms were disclosed. SAINT PAUL, Minn.–(BUSINESS WIRE)–MGC Diagnostics ...

MGC Diagnostics will be a more proactive, forward-looking organization with a renewed dedication to product innovation, unmatched customer service and support, and always anticipating and creating ...

ST. PAUL, Minn., Aug. 21, 2012 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, is pleased to announce its new trading symbol is effective today, August ...

SAINT PAUL, Minn.--(BUSINESS WIRE)--MGC Diagnostics Corporation (“MGC”), a global medical technology company dedicated to cardiorespiratory health solutions, and a portfolio company of Altus Capital ...

Good afternoon and welcome to the MGC Diagnostics’ Third Quarter Fiscal Year 2017 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s ...

NEW YORK, NY / ACCESSWIRE / December 5, 2017 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New ...

Altus Capital Partners is acquiring MGC Diagnostics Corp., a publicly traded medical technology company that focuses on cardiorespiratory health, for about $50.3 million. MGC Diagnostics in a press ...

Good morning and welcome to the MGC Diagnostics First Quarter Fiscal Year 2015 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s ...